SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17006999
Source:
http://linkedlifedata.com/resource/pubmed/id/17006999
Search
Subject
(
56
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0035525
,
umls-concept:C0445550
,
umls-concept:C0524910
,
umls-concept:C0796545
pubmed:issue
34
pubmed:dateCreated
2006-9-28
pubmed:abstractText
To assess the efficacy of peginterferon alpha 2b at doses of 50 microg weekly and 80 microg weekly (based on body weight) plus ribavirin in HCV genotype 2 and genotype 3 chronic hepatitis C patients.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/100883448
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha
,
http://linkedlifedata.com/resource/pubmed/chemical/Polyethylene Glycols
,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
,
http://linkedlifedata.com/resource/pubmed/chemical/Ribavirin
,
http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2b
,
http://linkedlifedata.com/resource/pubmed/chemical/peginterferon alfa-2b
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1007-9327
pubmed:author
pubmed-author:BanerjeeRupaR
,
pubmed-author:GuptaRajeshR
,
pubmed-author:LakhtakiaSandeepS
,
pubmed-author:RamakrishnaC HCH
,
pubmed-author:ReddyD NageshwarDN
,
pubmed-author:TandanManuM
pubmed:issnType
Print
pubmed:day
14
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5554-6
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:17006999-Adult
,
pubmed-meshheading:17006999-Antiviral Agents
,
pubmed-meshheading:17006999-Dose-Response Relationship, Drug
,
pubmed-meshheading:17006999-Drug Therapy, Combination
,
pubmed-meshheading:17006999-Female
,
pubmed-meshheading:17006999-Genotype
,
pubmed-meshheading:17006999-Hepacivirus
,
pubmed-meshheading:17006999-Hepatitis C, Chronic
,
pubmed-meshheading:17006999-Humans
,
pubmed-meshheading:17006999-Interferon-alpha
,
pubmed-meshheading:17006999-Male
,
pubmed-meshheading:17006999-Middle Aged
,
pubmed-meshheading:17006999-Pilot Projects
,
pubmed-meshheading:17006999-Polyethylene Glycols
,
pubmed-meshheading:17006999-Recombinant Proteins
,
pubmed-meshheading:17006999-Ribavirin
,
pubmed-meshheading:17006999-Treatment Outcome
pubmed:year
2006
pubmed:articleTitle
Efficacy of low dose peginterferon alpha-2b with ribavirin on chronic hepatitis C.
pubmed:affiliation
Asian Institute of Gastroenterology, Somajiguda 63661, Hyderabad, India.
pubmed:publicationType
Journal Article
,
Clinical Trial